The effects of chlorotrianisene (Tace) of kinetics of 3H-testosterone metabolism in patients with carcinoma of the prostate.
暂无分享,去创建一个
S. Baba | G. Janetschek | G. Jacobi | K. Pollow | K. Hahn
[1] G. Hutschenreiter,et al. Kinetics of 3H-testosterone and 3H-dihydrotestosterone metabolism in patients with benign prostatic hypertrophy. Effect of cyproterone acetate. , 1977, European urology.
[2] L. Srivastava,et al. The effects of diethylstilbestrol and medroxyprogesterone acetate on kinetics and production of testosterone and dihydrotestosterone in patients with prostatic carcinoma. , 1976, The Journal of clinical endocrinology and metabolism.
[3] H. Burger,et al. The assessment of results following endocrine therapy for prostatic cancer. , 1975, The Journal of urology.
[4] P. Knapstein,et al. Mode of action of progesterone, gestonorone capronate (Depostat) and cyproterone acetate (Androcur) on the metabolism of testosterone in human prostatic adenoma: in vitro and in vivo investigations. , 1975, Journal of steroid biochemistry.
[5] J. D. Fergusson,et al. Plasma testosterone: an accurate monitor of hormone treatment in prostatic cancer. , 1973, British journal of urology.
[6] H. Burger,et al. EFFECTS OF SYNTHETIC ORAL OESTROGENS IN NORMAL MEN AND PATIENTS WITH PROSTATIC CARCINOMA: LACK OF GONADOTROPHIN SUPPRESSION BY CHLOROTRIANISENE , 1973, Clinical endocrinology.
[7] R. Calandra,et al. Kinetics of 3 H-testosterone metabolism in patients with carcinoma of the prostate: effects of oestrogen administration. , 1971, Acta endocrinologica.
[8] R. N. Green,et al. Effect of the administration of estrogen on the disappearance of 3H-testosterone in the plasma of human subjects. , 1969, The Journal of clinical endocrinology and metabolism.
[9] V. Stevens,et al. The effects of sex steroids on gonadotropins. , 1965, American journal of obstetrics and gynecology.
[10] G. Calderini,et al. [CONSIDERATIONS ON A NEW SYNTHETIC ESTROGEN IN THE THERAPY OF CARCINOMA OF THE PROSTATE (CHLOROTRIANISENE, TACE)]. , 1964, Minerva urologica.
[11] B. Little,et al. The disappearance of 7-H-3-d-aldosterone in the plasma of normal subjects. , 1961, The Journal of clinical investigation.
[12] W. B. Kountz,et al. THE ACTION OF CHLOROTRIANISENE (TACE) WITH ANDROGEN ON NITROGEN RETENTION IN ELDERLY PEOPLE , 1959, Journal of the American Geriatrics Society.
[13] G. Carroll,et al. TACE in the treatment of carcinoma of the prostate: an 80-month survey. , 1958, The Journal of urology.
[14] G. Carroll,et al. Endocrine therapy in carcinoma of the prostate. , 1955, Journal of the American Medical Association.
[15] R. Hotchkiss,et al. The role of the adrenal cortex in prostatic cancer. , 1955, The Journal of urology.
[16] P. G. Smith,et al. Preliminary report on the clinical use of tace (chlorotrianisene) in treatment of prostatic carcinoma. , 1951, The Journal of urology.
[17] C. W. Emmens,et al. OESTROGENS AND PRO-OESTROGENS RELATED TO STILBENE AND TRIPHENYLETHYLENE , 1942 .
[18] C. W. Emmens,et al. PRECURSORS OF OESTROGENS , 1940 .